Key facts
- This page summarizes John R. Chiminski's Form 3 filing for QuidelOrtho Corp (QDEL).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 10 Dec 2024, 20:09.
John R. Chiminski - 06 Dec 2024 Form 3 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- Director
- Issuer ticker
- QDEL
- Reported as of
- 06 Dec 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 10 Dec 2024, 20:09:21 UTC
- Prior SEC filing
- 03 Oct 2023
- Next SEC filing
- 27 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Euna Greene, attorney-in-fact for John R. Chiminski
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John R. Chiminski filed Form 3 for QuidelOrtho Corp (QDEL) on 10 Dec 2024.
Change
- Previous filing in this sequence was filed on 03 Oct 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QDEL
holding
No securities beneficially owned.
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 06 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 06 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,523
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
2,523 shares will vest on May 22, 2025.
Footnote F2
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
SEC remarks
Exhibit 24.1 - Power of Attorney